Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 31,485 | 30,670 | 42,576 | 35,962 | 54,860 |
| Cost of Goods | 4,611 | 7,472 | 3,921 | 4,639 | 9,805 |
| Gross Profit | 26,874 | 23,198 | 38,655 | 31,323 | 45,055 |
| Operating Expenses | 48,146 | 199,413 | 49,892 | 44,273 | 49,493 |
| Operating Income | -20,661 | -175,743 | -10,316 | -12,311 | -3,633 |
| Other Income | 470 | 427 | 478 | 461 | 292 |
| Pre-tax Income | -20,191 | -175,316 | -9,838 | -11,850 | -3,341 |
| Income Tax | 25,656 | -9,036 | -1,654 | -5,326 | 311 |
| Net Income Continuous | -45,847 | -166,280 | -8,184 | -6,524 | -3,652 |
| Net Income | $-45,847 | $-166,280 | $-8,184 | $-6,524 | $-3,652 |
| EPS Basic Total Ops | -0.64 | -2.28 | -0.11 | -0.09 | -0.04 |
| EPS Basic Continuous Ops | -0.64 | -2.28 | -0.11 | -0.09 | -0.05 |
| EPS Diluted Total Ops | -0.64 | -2.28 | -0.11 | -0.09 | -0.05 |
| EPS Diluted Continuous Ops | -0.64 | -2.28 | -0.11 | -0.09 | -0.05 |
| EBITDA(a) | $-18,646 | $-173,660 | $-8,073 | $-10,190 | $-1,481 |